Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in the United Kingdom and the United States. The company develops ORX750, an orexin receptor 2 agonist, w...
Leadership
John J. Crowley CPA
Chief Financial Officer
Stephen J. Kanes M.D., Ph.D.
Head of R&D and Chief Medical Officer
Mario Alberto Accardi Ph.D.
CEO & Director
Raphael Deferiere CPA
Senior VP & Chief Accounting Officer
Tia L. Bush
Chief Technology & Quality Officer
Kristen K. Sheppard Esq., J.D.
Senior Vice President of Investor Relations & Corporate Communications
Iqbal J. Hussain L.L.B.
Chief Legal Officer, Chief Compliance Officer & Company Secretary
Karen M. Anderson
Chief People Officer
Gregory M. Weinhoff M.B.A., M.D.
Chief Business Officer
Charlene Stoudt
Senior Vice President of Clinical Development Operations
